This inventor holds 1 USPTO granted patent and 3 published patent applications and 3 EPO patents. Top assignee: Navigo Proteins Gmbh. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Manja Gloser-Bräunig: Innovator in Cancer Diagnosis and Treatment
Introduction: Manja Gloser-Bräunig is a prominent inventor based in Halle/Saale, Germany. She is currently associated with Navigo Proteins GmbH, where she focuses on developing innovative solutions for cancer diagnosis and treatment. Despite having no granted patents to her name, her contributions to the field are noteworthy.
Latest Patent Applications: Manja's latest patent applications include "Novel PSMA Specific Binding Proteins for Cancer Diagnosis and Treatment." This invention relates to new binding proteins that are specific for prostate-specific membrane antigen (PSMA). The invention further refers to PSMA binding proteins that comprise a diagnostically or therapeutically active component. Another significant application is "Novel FOLR1 Specific Binding Proteins for Cancer Diagnosis and Treatment." This invention focuses on new binding proteins that are specific for folate receptor alpha (FOLR1) and also includes components that are diagnostically or therapeutically active.
Conclusion: Manja Gloser-Bräunig is making significant strides in the field of cancer research through her innovative patent applications. Her work at Navigo Proteins GmbH highlights her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile